ccnlages <>[ only 1.1. 11, and 11%. whereas the remaining -1 children had no lymphocyte transformation at all. Again, the lymphocytes obtained from the spinal fluid in 3 evaluable patients of 7 examined, all affected by meningcal leukemia, and from the picuial effusion in 1 patient did not undergo any hlastic transfoi inatioii. It appears that a (|iiite different behavior concerning 1M1A blastogenesis of lymphocytes in AI.I. can be observed according lo the source (he lymphocytes come from. Si RIM. t'niv. of Milan. Iltilw Data were obtained on the inlluence of vincristine (7 X 10" r '.\i) on the in vitro incorporation of both (i-"C-orotatc into RNA and of 1-"C-lencine into proteins of leiikemic cells from acute lymphoevtic leukemia. Oroiate and leucine incorporations were meassurcd after 2 and 12 In of incubation. A total of 17 patients were examined. Most of the in vilro studies were conducted on peripheral blast cells. Ill I instances also bone marrow leukemic cells were tested. In any case ill which a good clinical response by vincristine administration was recorded, also a strong in vilro inhibition of both RXA and protein synthesis was observed. On the conuaiv, in the only 2 cases in which a definitive in vivo resistance to viiicristinc was observed, also an /;/ 'vitro lack of response was found. Practical implications of these studies will be disc ussed.
(>7. Gliuoncogcncsis in human platelets. K. A. ZurriNM'.R, N.
NAKAMURA, J. P. COIOMHO, and P. WAI.TKK.
UnivcisilaliKindtrklinik and I'niv. of linn, Switzerland. Quantitative evaluation of gluconcogcncsis in humans is difficult since liver and kidney are not suitable for repeated investigation. Therefore, gluconeogeiiesis in easily available tissue such as platelets was studied dining incubation in buffered solution. I pon addition of 20 HIM pyruvatc glucose formation in the incubation medium amounted lo (i.99 pinoles hi 10" platelets and glycogen utilization was inhibited to 28.8';. Incorporation of label from pyruvatc-2-"C into carbohydrates revealed 2.22 juinoles pyruvate iiicorporatecliir 1(1" platelets. These results are interpreted as evidence for the existence of gluconeogeiiesis in human platelets. In two patients with glycogen storage disease type I incorporation of label from pyruvale^-^C into carbohydrates was decreased to 0.95 pinole, hr 10" platelets. Only 1'i of the total radioactivity was found to be in glucose in these patients as compared to 81'', in normals, indicating that most radioactivity was incorporated into nonglucose carbohydrates, probably glycogen. Incorporation of label from pvi uvatc-2-"C into carbohydrates by platelets of two patients with glycogen storage disease type III showed no increase in comparison to normals; however, in these patients '.I.VJ of the label was found in glucose. This finding indicates that in type III glyeogenosis a greater relative part of pyruvate is incorporated into glucose than in normals. The conclusion is drawn from these studies that human platelets might prove to be a valuable material for sluclv ing gluconcogcnesis under various conditions.
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